NCT04791371View on ClinicalTrials.gov

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 17, 2022

Primary Completion Date

September 1, 2026

Study Completion Date

December 1, 2027

Conditions
Type 2 DiabetesOverweight and Obesity
Interventions
BEHAVIORAL

Cardiovascular exercise

15 weeks of cardiovascular exercise 3x/week for 50 minutes/session

Trial Locations (2)

22908

RECRUITING

University of Virginia, Charlottesville

80045

RECRUITING

University of Colorado, Aurora

All Listed Sponsors
collaborator

University of Virginia

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Colorado, Denver

OTHER